|
Mar 1
|
Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
|
|
Mar 1
|
Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?
|
|
Feb 28
|
Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds
|
|
Feb 28
|
Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ...
|
|
Feb 27
|
Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Feb 27
|
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates
|
|
Feb 27
|
Amphastar: Q4 Earnings Snapshot
|
|
Feb 27
|
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 Sales Targets, Stock Drops 12.1%
|
|
Feb 27
|
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024
|
|
Feb 26
|
Amphastar Pharmaceuticals' (NASDAQ:AMPH) 15% CAGR outpaced the company's earnings growth over the same five-year period
|
|
Feb 26
|
Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow
|
|
Aug 28
|
Amphastar Pharmaceuticals to Present at the 2024 Wells Fargo Healthcare Conference
|
|
Jun 12
|
Insider Sale: Director Floyd Petersen Sells Shares of Amphastar Pharmaceuticals Inc (AMPH)
|
|
May 22
|
Amphastar Receives FDA Approval for Albuterol Sulfate Inhalation Aerosol
|
|
May 15
|
Implied Volatility Surging for Amphastar (AMPH) Stock Options
|
|
May 10
|
Amphastar Pharmaceuticals Reports Strong First Quarter Earnings, Surpassing Analyst Revenue ...
|
|
May 10
|
Amphastar Pharmaceuticals First Quarter 2024 Earnings: EPS: US$0.90 (vs US$0.54 in 1Q 2023)
|
|
May 9
|
Amphastar Pharmaceuticals to Present at the Bank of America Securities Health Care Conference
|
|
Jan 11
|
Amphastar Pharmaceuticals (AMPH) Registers a Bigger Fall Than the Market: Important Facts to Note
|
|
Jan 2
|
Amphastar Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
|